Delhi-based biotechnology company Panacea Biotec is awaiting a nod from the World Health Organization (WHO) to resume supplying vaccines for the world immunisation programme from its units at Lalru (Haryana) and Baddi (Himachal Pradesh).

Speaking to Business Standard, a senior company official said, “We expect WHO officials to visit our units in Lalru and Baddi for prequalification next month. Recently, we had shifted the Easyfive pentavalent vaccine to our new unit in Baddi and once the plant is approved by WHO, we will be able to resume supplies for its immunisation programme.”